Vor Biopharma Inc. (VOR) — 10-Q Filings

10-Q Filings (6)

• Vor Biopharma's Net Loss Explodes to $2.4B on Warrant Liabilities — Nov 13, 2025 Risk: high
  Vor Biopharma Inc. reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $2.419 billion, a substantial rise from $8
• Vor Biopharma's Q2 Loss Explodes to $1.6B on Warrant Liabilities, R&D Surge — Aug 12, 2025 Risk: high
  Vor Biopharma Inc. reported a substantial net loss of $1.606 billion for the six months ended June 30, 2025, a significant increase from the $58.643 million los
• Vor Biopharma Files Q1 2025 10-Q — May 14, 2025 Risk: medium
  Vor Biopharma Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information and business operations for the first quarter o
• Vor Biopharma Files Q3 2024 10-Q — Nov 7, 2024 Risk: medium
  Vor Biopharma Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial position and operational highlights. Key financia
• Vor Biopharma Files Q2 2024 10-Q — Aug 8, 2024 Risk: medium
  Vor Biopharma Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results and provided updates on its business operation
• Vor Biopharma Inc. Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: medium
  Vor Biopharma Inc. (VOR) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Vor Biopharma Inc. filed a 10-Q report for the period ending March 31, 202

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX